Related references
Note: Only part of the references are listed.Pharmacokinetics of a novel submicron budesonide dispersion for nebulized delivery in asthma
Stephen B. Shrewsbury et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Enhancing intestinal drug solubilisation using lipid-based delivery systems
Christopher J. H. Porter et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Review of the TAIFUN (R) multidose dry powder inhaler technology
Kirk A. Overhoff et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2008)
High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers
Wei Yang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Inhaled nanoparticles - A current review
Wei Yang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Amorphous Cyclosporin Nanodispersions for Enhanced Pulmonary Deposition and Dissolution
Jasmine M. Tam et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Rate-limiting steps of oral absorption for poorly water-soluble drugs in dogs; Prediction from a miniscale dissolution test and a physiologically-based computer simulation
Ryusuke Takano et al.
PHARMACEUTICAL RESEARCH (2008)
Preclinical safety evaluation of inhaled cyclosporine in propylene glycol
Tao Wang et al.
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG (2007)
The utility of cyclodextrins for enhancing oral bioavailability
Rebecca L. Carrier et al.
JOURNAL OF CONTROLLED RELEASE (2007)
A formulation comparison, using a solution and different nanosuspensions of a poorly soluble compound
Kalle Sigfridsson et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2007)
Pharmacokinetics of inhaled monodisperse beclomethasone as a function of particle size
J. E. Esposito-Festen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Current perspectives of solubilization: Potential for improved bioavailability
Subrata Mallick et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2007)
Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study
C. M. Lowry et al.
TRANSPLANT INFECTIOUS DISEASE (2007)
Novel poloxamer-based nanoemulsions to enhance the intestinal absorption of active compounds
Carsten Bruesewitz et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Pharmacokinetic and pharmacodynamic properties important for inhaled corticosteroids
Guenther Hochhaus
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2007)
Novel ultra-rapid freezing particle engineering process for enhancement of dissolution rates of poorly water-soluble drugs
Kirk A. Overhoff et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2007)
Formulation of parenteral microemulsion containing itraconazole
Yun-Seok Rhee et al.
ARCHIVES OF PHARMACAL RESEARCH (2007)
Inhaling medicines: delivering drugs to the body through the lungs
John S. Patton et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Particle engineering for pulmonary drug delivery
Albert H. L. Chow et al.
PHARMACEUTICAL RESEARCH (2007)
Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system
Colin W. Pouton
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Cryogenic liquids, nanoparticles, and microencapsulation
Troy Purvis et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery
Masahiro Sakagami
ADVANCED DRUG DELIVERY REVIEWS (2006)
Is the oral route possible for peptide and protein drug delivery
Mariko Morishita et al.
DRUG DISCOVERY TODAY (2006)
Plasma concentrations of inhaled corticosteroids in relation to airflow obstruction in asthma
Kevin J. Mortimer et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles
S. M. Wong et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Increasing exposure levels cause an abrupt change in the absorption and metabolism of acutely inhaled benzo(a)pyrene in the isolated, ventilated, and perfused lung of the rat
Per Ewing et al.
TOXICOLOGICAL SCIENCES (2006)
Single dose and multiple dose studies of itraconazole nanoparticles
Jason M. Vaughn et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2006)
Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery
Sunday A. Shoyele et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model
Jason T. McConville et al.
PHARMACEUTICAL RESEARCH (2006)
In vivo efficacy of aerosolized nanostructured itraconazole formulations for prevention of invasive pulmonary aspergillosis
BJ Hoeben et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Systemic delivery of drugs to humans via inhalation
I Gonda
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG (2006)
Therapy of systemic fungal infections: A pharmacologic perspective
V Wiebe et al.
CLINICAL TECHNIQUES IN SMALL ANIMAL PRACTICE (2005)
Advances and challenges in management of invasive mycoses
TF Patterson
LANCET (2005)
Fluticasone propionate plasma concentration and systemic effect: Effect of delivery device and duration of administration
GJ Whelan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Dosimetric adjustments for interspecies extrapolation of inhaled poorly soluble particles (PSP)
AM Jarabek et al.
INHALATION TOXICOLOGY (2005)
The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence
KV Clemons et al.
MEDICAL MYCOLOGY (2005)
Monitoring the initial pulmonary absorption of two different beclomethasone dipropionate aerosols employing a human lung reperfusion model -: art. no. 21
M Freiwald et al.
RESPIRATORY RESEARCH (2005)
Equivalent lung deposition of budesonide in vivo:: a comparison of dry powder inhalers using a pharmacokinetic method
S Lähelmä et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Cyclodextrins in drug delivery: An updated review
R Challa et al.
AAPS PHARMSCITECH (2005)
Penetration enhancers
AC Williams et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
The pharmacokinetics of nebulized nanocrystal budesonide suspension in healthy volunteers
WK Kraft et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Newer systemic antifungal agents - Pharmacokinetics, safety and efficacy
HW Boucher et al.
DRUGS (2004)
Antidepressant Properties of Substance P Antagonists: Relationship to Monoaminergic Mechanisms?
Albert Adell
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2004)
Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs
JH Hu et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2004)
Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers
MT Newhouse et al.
CHEST (2003)
Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients
V Monforte et al.
TRANSPLANTATION (2003)
Unexpected gas casualties in Moscow: A medical toxicology perspective
PM Wax et al.
ANNALS OF EMERGENCY MEDICINE (2003)
Challenges for the oral delivery of macromolecules
M Goldberg et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Enhanced aqueous dissolution of a poorly water soluble drug by novel particle engineering technology: Spray-freezing into liquid with atmospheric freeze-drying
TL Rogers et al.
PHARMACEUTICAL RESEARCH (2003)
Improvement of pulmonary absorption of cyclopeptide FK224 in rats by co-formulating with β-cyclodextrin
T Nakate et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2003)
Lung deposition and pharmacokinetics of cyclosporine after aerosolization in lung transplant patients
GJ Burckart et al.
PHARMACEUTICAL RESEARCH (2003)
Comparison of the lung absorption of FK224 inhaled from a pressurized metered dose inhaler and a dry powder inhaler by healthy volunteers
T Nakate et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2003)
A mechanistic approach to understanding the factors affecting drug absorption: A review of fundamentals
MN Martinez et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate
I Bekersky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Pharmacokinetics and systemic activity of fluticasone via Diskus® and pMDI, and of budesonide via Turbuhaler®
L Thorsson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man
PT Daley-Yates et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
In the lung aerosol cyclosporine provides a regional concentration advantage over intramuscular cyclosporine
SN Mitruka et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2000)
Safety of inhaled and intranasal corticosteroids - Lessons for the new millennium
BJ Lipworth et al.
DRUG SAFETY (2000)
Aerosol delivery of amphotericin B desoxycholate (Fungizone) and liposomal amphotericin B (AmBisome): Aerosol characteristics and in-vivo amphotericin B deposition in rats
EJ Ruijgrok et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2000)
A study comparing the clinical pharmacokinetics, pharmacodynamics, and tolerability of triamcinolone acetonide HFA-134a metered-dose inhaler and budesonide dry-powder inhaler following inhalation administration
D Argenti et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Absorption kinetics after inhalation of fluticasone propionate via the Diskhaler (R), Diskus (R) and metered-dose inhaler in healthy volunteers
C Brindley et al.
CLINICAL PHARMACOKINETICS (2000)
Share Paper
